A first-time analysis using the National Inpatient Sample (NIS) database sought to examine the relationship between polycystic ovary syndrome (PCOS) and gynecologic cancers, including endometrial cancer.
...
In June, following a placebo-controlled trial, the FDA approved pembrolizumab with chemotherapy to treat patients with primary advanced or recurrent endometrial carcinoma.
In April, the Society of Radiologists in Ultrasound released a consensus statement outlining recommendations for healthcare providers with the goal of improving the imaging, detection, and evaluation of...
Gynecologic oncologists currently lack risk models that can accurately predict an endometrial cancer diagnosis at the time of hysterectomy for endometrial intraepithelial neoplasia. To fill this gap,...
This COVID-19 roundup includes coverage of the latest and final COVID-19 treatment guidelines by the NIH, the effectiveness of the COVID-19 vaccine in preventing pediatric long COVID, the spring 2024...
Researchers developed a retrospective cohort study to examine the reoperation rates and health care costs associated with reoperation for patients who underwent breast-conserving surgery.
Researchers examined the characteristics and trends related to the increased mortality rates associated with overdose in pregnant and postpartum women.
Using data from observational and clinical trials, researchers examined the association between advancements in metastatic breast cancer treatment and the observed improvement in breast cancer mortality...
In a single-group trial, researchers assessed the safety and risks associated with interrupting endocrine therapy for women with stage I, II, or III breast cancer attempting pregnancy.
